Medbox Inc. (OTC Markets: MDBX), a provider of patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities and medical groups worldwide, is well positioned to capitalize on the so-called marijuana “green rush” in the United States, following a new medical marijuana bill that would allow for the drug’s use through licensed dispensaries in Florida.
With a product that’s better defined than companies like HEMP Inc. (OTCQB: HEMP) and Medical Marijuana Inc. (OTCQB: MJNA), Medbox is focused on helping dispensaries remain in compliance with state and federal laws. The company also has an enormous long-term play in the pharmaceutical industry with its automated biometric dispensing solutions, which could unlock significant additional value over the coming quarters and years.
Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), announced that last Wednesday members of the Florida House and Senate introduced a new medical marijuana bill that would allow for the drug’s use through licensed dispensaries. Nine other States have pending legislation to legalize medicinal marijuana including: Illinois, Iowa, Kansas, Kentucky, Maryland, New Hampshire, North Carolina, New York and Oklahoma. This current momentum was predicted years ago in a research report. Jon B. Gettman, PhD, a marijuana reform activist, a leader of the Coalition for Rescheduling Cannabis, and former head of the National Organization for the Reform of Marijuana Laws issued a report entitled “Marijuana Production in the United States (2006)” published in the Bulletin of Cannabis Reform, December 2006 and posted on the www.drugscience.org website.